Krushangi Shah

Krushangi Shah, PhD, is a Scientist II at Metagenomi, specializing in genome editing, assay development, and pre-clinical in-vivo testing since February 2022. Previously, Krushangi served as a Graduate Research Assistant at Wright State University, where significant accomplishments included identifying a novel therapeutic target for metastatic, drug-resistant ER+ breast cancer and discovering downstream targets using advanced proteomics techniques. Additional experience includes roles as a Graduate Research Assistant at the University of Missouri-Kansas City, where research focused on HIV-associated neurocognitive disorder, and as a Senior Research Associate at Lambda Therapeutic Research, addressing urgent safety concerns for regulatory agencies. Krushangi's academic background includes a Ph.D. in Biomedical Sciences from Wright State University, an M.Pharm in Pharmacology from Nirma University, and a B.Pharm in Pharmacy from Charotar University of Science and Technology.